US Patent RE49825 Piperidinyl nociceptin receptor compounds
Patent RE49825 was granted and assigned to ASTRAEA THERAPEUTICS, LLC on February, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 30, 2021
0
Date of Patent
February 6, 2024
0
Patent Applicant
Patent Application Number
17245700
0
Patent Inventor Names
Michael Meyer
0
Nurulain Zaveri
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent RE49825 Piperidinyl nociceptin receptor compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.